Thomas Weimer

Person

Gladenbach, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Truncated von Willebrand factor polypeptides for extravascular admi...
- Patent number 11,890,327
- Issue date Feb 6, 2024
- CSL BEHRING LENGNAU AG
- Sabine Pestel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Truncated von Willebrand Factor polypeptides for treating hemophilia
- Patent number 11,814,421
- Issue date Nov 14, 2023
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand Factor
- Patent number 11,564,976
- Issue date Jan 31, 2023
- CSL Behring Lengnau AG
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified von Willebrand factor having improved half-life
- Patent number 11,155,601
- Issue date Oct 26, 2021
- CSL BEHRING LENGNAU AG
- Michael Moses
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulation of FVIII immunogenicity by truncated VWF
- Patent number 11,141,466
- Issue date Oct 12, 2021
- CSL BEHRING LENGNAU AG
- Anne Verhagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand factor
- Patent number 10,905,747
- Issue date Feb 2, 2021
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand factor
- Patent number 10,772,936
- Issue date Sep 15, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- G01 - MEASURING TESTING
Information Patent Grant
Truncated von Willebrand factor polypeptides for treating hemophilia
- Patent number 10,688,157
- Issue date Jun 23, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent complex of von Willebrand Factor and factor VIII, composit...
- Patent number 9,878,017
- Issue date Jan 30, 2018
- CSL Ltd.
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Von willebrand factor variants having improved factor VIII binding...
- Patent number 9,458,223
- Issue date Oct 4, 2016
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coagulation factor X polypeptides with modified activation properties
- Patent number 9,347,051
- Issue date May 24, 2016
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII, von Willebrand factor or complexes thereof with prolon...
- Patent number 9,290,561
- Issue date Mar 22, 2016
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coagulation factor X polypeptides with modified activation properties
- Patent number 9,249,404
- Issue date Feb 2, 2016
- CSL Behring GmbH
- Stefan Schulte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified vitamin K dependent polypeptides
- Patent number 8,828,939
- Issue date Sep 9, 2014
- CSL Behring GmbH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified coagulation factor VIIa with extended half-life
- Patent number 8,765,915
- Issue date Jul 1, 2014
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified coagulation factors with prolonged in vivo half-life
- Patent number 8,754,194
- Issue date Jun 17, 2014
- CSL Behring GmbH
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII, von willebrand factor or complexes thereof with prolon...
- Patent number 8,575,104
- Issue date Nov 5, 2013
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic application of Kazal-type serine protease inhibitors
- Patent number 8,283,319
- Issue date Oct 9, 2012
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteolytically cleavable fusion proteins with high molar specific...
- Patent number 7,939,632
- Issue date May 10, 2011
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mutants of the factor VII-activating protease and detection methods...
- Patent number 7,863,009
- Issue date Jan 4, 2011
- CSL Behring GmbH
- Juergen Roemisch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Marburg I mutant of factor VII activating protease (FSAP) as risk f...
- Patent number 7,803,569
- Issue date Sep 28, 2010
- CSL Behring GmbH
- Stefan Kiechl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutants of the factor VII-activating protease and detection methods...
- Patent number 7,442,514
- Issue date Oct 28, 2008
- CSL Behring GmbH
- Juergen Roemisch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Marburg I mutant of factor VII activating protease (FSAP) as risk f...
- Patent number 7,153,679
- Issue date Dec 26, 2006
- Aventis Behring GmbH
- Stefan Kiechl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutants of the factor VII-activating protease and detection methods...
- Patent number 6,831,167
- Issue date Dec 14, 2004
- Aventis Behring GmbH
- Juergen Roemisch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for growing circoviruses
- Patent number 6,573,081
- Issue date Jun 3, 2003
- Aventis Behring GmbH
- Dieter Bernhardt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Labeled primer for use in and detection of target nucleic acids
- Patent number 6,248,526
- Issue date Jun 19, 2001
- Aventis Behring, GmbH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Procedure for the detection of high virus concentrations in blood p...
- Patent number 6,183,999
- Issue date Feb 6, 2001
- Aventis Behring GmbH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII
- Publication number 20220348637
- Publication date Nov 3, 2022
- CSL Behring Lengnau AG
- Marco HOFMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR IX VARIANTS AND USES THEREOF IN THERAPY
- Publication number 20220154161
- Publication date May 19, 2022
- CSL Behring Lengnau AG
- Philipp CLAAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR EXTRAVASCULAR ADMI...
- Publication number 20210268071
- Publication date Sep 2, 2021
- CSL BEHRING LENGNAU AG
- Sabine PESTEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20210121535
- Publication date Apr 29, 2021
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20200368327
- Publication date Nov 26, 2020
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF
- Publication number 20200197495
- Publication date Jun 25, 2020
- CSL Behring Lengnau AG
- Anne VERHAGEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20200095567
- Publication date Mar 26, 2020
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20190263890
- Publication date Aug 29, 2019
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20180161402
- Publication date Jun 14, 2018
- CSL Behring Recombinant Facility AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20180153968
- Publication date Jun 7, 2018
- CSL Behring Recombinant Facility AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20180119128
- Publication date May 3, 2018
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSIT...
- Publication number 20180092966
- Publication date Apr 5, 2018
- CSL Limited
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED VON WILLEBRAND FACTOR HAVING IMPROVED HALF-LIFE
- Publication number 20180051067
- Publication date Feb 22, 2018
- CSL Behring Recombinant Facility AG
- Michael MOSES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
- Publication number 20170080061
- Publication date Mar 23, 2017
- CSL BEHRING GMBH
- Thomas WEIMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPLEX
- Publication number 20160200794
- Publication date Jul 14, 2016
- CSL Limited
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20160010074
- Publication date Jan 14, 2016
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Von Willebrand Factor Variants Having Improved Factor VIII Binding...
- Publication number 20140357564
- Publication date Dec 4, 2014
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
- Publication number 20140356346
- Publication date Dec 4, 2014
- CSL BEHRING GMBH
- Thomas WEIMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE
- Publication number 20140273096
- Publication date Sep 18, 2014
- CSL BEHRING GMBH
- Stefan SCHULTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
- Publication number 20140248686
- Publication date Sep 4, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20140072561
- Publication date Mar 13, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
- Publication number 20130337532
- Publication date Dec 19, 2013
- CSL BEHRING GMBH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Interleukin-11 Fusion Proteins
- Publication number 20120258072
- Publication date Oct 11, 2012
- Monika Kröz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20110189182
- Publication date Aug 4, 2011
- CSL Behring GmbH
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20110183907
- Publication date Jul 28, 2011
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified Coagulation Factor VIII With Enhanced Stability and Its De...
- Publication number 20110124565
- Publication date May 26, 2011
- Hans-Peter Hauser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Albumin-Fused Kunitz Domain Peptides
- Publication number 20110092413
- Publication date Apr 21, 2011
- Novozymes BioPharma DK A/S
- Hans-Peter Hauser
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS
- Publication number 20100279923
- Publication date Nov 4, 2010
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides
- Publication number 20100222554
- Publication date Sep 2, 2010
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Interleukin-11 Fusion Proteins
- Publication number 20100143973
- Publication date Jun 10, 2010
- Monika Kröz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas Weimer

Person

Patents Grantslast 30 patents

Truncated von Willebrand factor polypeptides for extravascular admi...

Truncated von Willebrand Factor polypeptides for treating hemophilia

Methods for preparing modified von Willebrand Factor

Modified von Willebrand factor having improved half-life

Modulation of FVIII immunogenicity by truncated VWF

Methods for preparing modified von Willebrand factor

Methods for preparing modified von Willebrand factor

Truncated von Willebrand factor polypeptides for treating hemophilia

Covalent complex of von Willebrand Factor and factor VIII, composit...

Von willebrand factor variants having improved factor VIII binding...

Coagulation factor X polypeptides with modified activation properties

Factor VIII, von Willebrand factor or complexes thereof with prolon...

Coagulation factor X polypeptides with modified activation properties

Modified vitamin K dependent polypeptides

Modified coagulation factor VIIa with extended half-life

Modified coagulation factors with prolonged in vivo half-life

Factor VIII, von willebrand factor or complexes thereof with prolon...

Therapeutic application of Kazal-type serine protease inhibitors

Proteolytically cleavable fusion proteins with high molar specific...

Mutants of the factor VII-activating protease and detection methods...

Marburg I mutant of factor VII activating protease (FSAP) as risk f...

Mutants of the factor VII-activating protease and detection methods...

Marburg I mutant of factor VII activating protease (FSAP) as risk f...

Mutants of the factor VII-activating protease and detection methods...

Method for growing circoviruses

Labeled primer for use in and detection of target nucleic acids

Procedure for the detection of high virus concentrations in blood p...

Patents Applicationslast 30 patents

POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII

FACTOR IX VARIANTS AND USES THEREOF IN THERAPY

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR EXTRAVASCULAR ADMI...

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

MODULATION OF FVIII IMMUNOGENICITY BY TRUNCATED VWF

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSIT...

MODIFIED VON WILLEBRAND FACTOR HAVING IMPROVED HALF-LIFE

MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE

COMPLEX

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

Von Willebrand Factor Variants Having Improved Factor VIII Binding...

MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE

MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE

THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...

THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY

Interleukin-11 Fusion Proteins

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...

Modified Coagulation Factor VIII With Enhanced Stability and Its De...

Albumin-Fused Kunitz Domain Peptides

THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS

Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides

Interleukin-11 Fusion Proteins